Turenne Capital invests €9.8m in Infimed

The deal was made via the GP’s Capital Santé 1 fund, along with the co-investment of its Emergence ETI fund. It also used capital from Nord Capital fund, which is owned by Crédit Agricole Nord de France and Turenne Capital.

Turenne acquired a majority stake in the business. The management team continues to lead the company and includes founder Olivier Bancquart and CEO Robert Gonzalo.

With the French medical equipment market worth north of €4bn, Infimed is operating in a favourable environment, according to Turenne Capital. The company intends to expand its range of equipment financing across regions in France with plans to expand its range outside France.

Turenne Capital Partenaires held a first close after gathering €60m in commitments for its Emergence ETI fund in October 2016, accoring to Unquote Data.

Company
Founded in 2012 and headquartered in Lille, Infimed provides rental services for medical equipment and offers financing services for the devices. To date Infimed have provided a total of €120m in financing and posted a turnover of €40m in 2017.

People
Infimed – Robert Gonzalo (CEO). 
Turenne Capital – Benoît Pastour (general director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• France
• Turenne Capital Partenaires
• Nord Capital Investissement (Participex)